FP6 information day for biopharmaceutical SMEs
The main aim of the day is to provide small and medium biopharmaceutical companies in Europe with a better understanding of the benefits of participating in FP6, and more specifically, in the second call for the 'life sciences, genomics and biotechnology for health' priority.
A series of sessions will also take place, in which companies will be able to speak directly with representatives from the European Commission about the areas that they would like to see included in the future calls.
Furthermore, Commission representatives will give an overview of the application and evaluation process for FP6 project proposals.For further information, please consult the following web address:
http://www.ebe-efpia.org/Conferences/6FPdefault.htm(odnośnik otworzy się w nowym oknie)